Distrustful of Health Agencies, These Voters Cheer Trump’s Picks to Run Them
Some voters galvanized by Robert F. Kennedy Jr.’s pledge to “Make America Healthy Again” said they believed the health establishment was dismissive and even corrupt.
Distrustful of Health Agencies, These Voters Cheer Trump’s Picks to Run Them
Some voters galvanized by Robert F. Kennedy Jr.’s pledge to “Make America Healthy Again” said they believed the health establishment was dismissive and even corrupt.
Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target
The agency long benefited from broad bipartisan support. But Republican criticism has intensified, and new choices for top health posts hope to upend the organization.
¿Cómo funciona el Ozempic?
Te compartimos una guía sobre este y otros medicamentos populares utilizados para la diabetes y la pérdida de peso.
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics
When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.
Los otros 50 hombres acusados en el juicio de Gisèle Pelicot
Dominique Pelicot invitó a hombres a violar a su esposa, a la que había drogado. Los medios de comunicación franceses los llaman “señor cualquiera” porque proceden de entornos muy ordinarios.
The 50 Others Accused in France’s Pelicot Rape Trial
Dominique Pelicot invited men to rape his wife, whom he had drugged. The French media call them “Mr. Every Man” because they come from such ordinary backgrounds.
New Amgen Drug MariTide Shows Promising Weight Loss in Early Data
The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent weight loss in a small group of patients.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.